Product Information

DILTIAZEM 24H ER(LA) 360 MG TB is a generic product labeled by Cipla USA Inc., priced at $1.8587 per EA under NDC 69097099605. Its NADAC has been published 133 times since Feb 7, 2024.

FDA first approved this application on Apr 6, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(LA) 360 MG TB

diltiazem hydrochloride
$1.8587per EA

Strength

360 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097099605

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216327

FDA Approved

4/6/2023

TE Code

AB

On Market Since

6/12/2023

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has been published 133 times since Feb 7, 2024, and over the history we have for it it has declined 37.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8587 per EA
All-time high$2.9843 (Mar 13, 2024)
All-time low$1.8587 (Aug 19, 2026)
52-week high$2.6613
52-week low$1.8587
Median price$2.5204
Average price$2.4445
Largest weekly change+33.4% (Jun 19, 2024)
Weeks tracked133
Tracking sinceFeb 7, 2024

Price History

1W

-10.4%

1M

-14.9%

3M

-17.8%

6M

-12.3%

1Y

-30.1%

3Y

N/A

5Y

N/A

All

-37.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(LA) 360 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(LA) 360 MG TB, manufactured by Cipla USA Inc., is $1.8587 per EA (NDC 69097099605), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(LA) 360 MG TB changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has declined 37.7%. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(LA) 360 MG TB?

Since Feb 7, 2024, the NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has ranged from a low of $1.8587 (Aug 19, 2026) to a high of $2.9843 (Mar 13, 2024), with a median of $2.5204 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(LA) 360 MG TB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(LA) 360 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 24H ER(LA) 360 MG TB?

DILTIAZEM 24H ER(LA) 360 MG TB (NDC 69097099605) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.